Newfound Research’s Embecta EMBC Stock Holding History

Newfound Research’s Portfolio EMBC Stock Details EMBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3K	Hold	97	–	–	0.01%	131
2022 Q2	$2K	Buy	+97	New	+$2.79K	﹤0.01%	131

Other funds holding EMBC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

YAM

Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Newfound Research's EMBC Position: Q3 2022 in Review

Newfound Research held its Embecta (EMBC) position steady in Q3 2022 at 97 shares worth $3K. The position accounts for 0.01% of the portfolio, ranked #131.

Newfound Research first reported a position in EMBC in Q2 2022 and has held it in 2 quarters since. 461 funds tracked by Wall St. Rank hold EMBC as of Q3 2022.

Newfound Research held 97 shares of Embecta worth $3K as of Q3 2022.
Newfound Research left its Embecta share count unchanged in Q3 2022.
Embecta made up 0.01% of Newfound Research's portfolio in Q3 2022, its #131 holding.
Newfound Research first reported a position in Embecta in Q2 2022 and has held it in 2 quarters since.
461 funds tracked by Wall St. Rank held Embecta as of Q3 2022.

Based on Newfound Research's 13F filing for Q3 2022, filed 13 Oct 2022.